Vaccination key to preventing a devastating flu season
An expert weighs in on the factors driving influenza cases in 2023 and how pharmacists can encourage vaccination in all patients.
A wrap-around approach to managing endometriosis
With a new medicine available for endometriosis, here's how pharmacists can screen for the ‘missed disease’ and discuss appropriate options.
ATAGI highlights progress amid resurgent diseases
ATAGI flagged worrying vaccine coverage declines and renewed disease threats, with pharmacists tipped to boost community protection.
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2
A pharmacist’s role in drug discovery
Pharmacists have a critical role to play in the optimisation of drug discovery research due to the diversity of their drug knowledge.
Aus CVD risk: the Australian cardiovascular disease risk calculator
The 2023 Aus CVD Risk calculator and guideline provide updated evidence-based recommendations for identifying, assessing, communicating and managing CVD risk in a primary prevention setting.













